| Market revenue in 2024 | USD 162.1 million |
| Market revenue in 2030 | USD 305.3 million |
| Growth rate | 11.1% (CAGR from 2025 to 2030) |
| Largest segment | Drug discovery |
| Fastest growing segment | Drug Validation |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemical Analysis, Drug Discovery, Drug Validation |
| Key market players worldwide | Dassault Systemes SE, Agilent Technologies Inc, PerkinElmer, ChemAxon, Bio-Rad Laboratories Inc, Schrodinger Inc Ordinary Shares, Molecular Discovery, ACD labs |
Publish Date: Jan 06, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Dassault Systemes SE | View profile | 23,811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | www.3ds.com |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | www.schrodinger.com |
| ChemAxon | View profile | 101-250 | Utica, New York, United States, North America | chemaxon.com/company |
| ACD labs | View profile | 51-100 | Toronto, Ontario, Canada, North America | www.acdlabs.com |
| Molecular Discovery | View profile | 11-50 | Borehamwood, Hertford, United Kingdom, Europe | www.moldiscovery.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Chemoinformatics Market Outlook will help companies and investors design strategic landscapes.
Drug Discovery was the largest segment with a revenue share of 48.61% in 2024.
Horizon Databook has segmented the Canada chemoinformatics market based on chemical analysis, drug discovery, drug validation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada chemoinformatics market, including forecasts for subscribers. This country databook contains high-level insights into Canada chemoinformatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
